Related Experiment Video
Updated: Sep 14, 2025
08:02
Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots
Published on: October 25, 2024
444
Percutaneous Thrombectomy Using AngioJet in Acute Pulmonary Embolism With Clot in Transit.
Atif Saleem Siddiqui1,2,3
1Houston Methodist Academic Institute Houston Texas USA.
Respirology Case Reports
|July 24, 2025
Summary
Percutaneous pulmonary thrombectomy with the AngioJet device shows promise for treating acute pulmonary embolism with clot in transit in high-risk patients. More research is needed to confirm its safety and effectiveness in these populations.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Pulmonary Medicine
Background:
- Acute pulmonary embolism (PE) poses a significant risk, especially with a clot in transit.
- High-risk PE patients often require advanced interventions.
Purpose of the Study:
- To evaluate the feasibility of percutaneous pulmonary thrombectomy for acute PE with clot in transit.
- To assess the use of the AngioJet device in selected high-risk patients.
Main Methods:
- Percutaneous pulmonary thrombectomy utilizing the AngioJet system.
- Application in a cohort of high-risk patients with acute PE and clot in transit.
Main Results:
- The AngioJet device demonstrated feasibility for managing acute PE with clot in transit.
- The procedure was applied in selected high-risk individuals.
Conclusions:
- Percutaneous pulmonary thrombectomy is a viable option for specific high-risk PE patients with clot in transit.
- Further large-scale studies are essential to confirm safety and efficacy.
Related Concept Videos
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
44
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
44
01:29Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
01:29Pulmonary Embolism I: Introduction
46
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
46
01:27Pulmonary Embolism III: Nursing Management
42
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
42
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
254
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
254
01:27Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29